About us

Distribution 2020 (proposed)
CHF 3.40

(2019: CHF 3.05)
Dividend policy

Board of Directors
Team
Facts & Figures
Stock Exchange
Contact
BB Biotechs building blocks

Latest News

Download

Media releases / 17.01.2020

BB Biotech benefits from M&A transactions
Biotech Sector

Follow us
BB Biotech App
App Download

What is biotechnology?
Growth Drivers
Sector in Numbers
Investment themes
Genetic Medicine

Biotechnology is characterized by its innovative strength

Latest News

Download

Media releases / 17.01.2020

BB Biotech benefits from M&A transactions
Strategy & Portfolio

Distribution 2020 (proposed)
CHF 3.40

(2019: CHF 3.05)
Dividend policy

Investment Strategy
Investment Process
Risk Management
Portfolio
Our Holdings
Investment areas

Upcoming Event

21.02.2020:

Annual report 2019, 7 a.m.

CALENDAR
Investor Relations

Distribution 2020 (proposed)
CHF 3.40

(2019: CHF 3.05)
Dividend policy

App & Social Media
Share Price
Facts & Figures
Newscenter
Corporate Calendar
Dividend policy
News Service
Newsletter
Contact

Latest News

Download

Media releases / 17.01.2020

BB Biotech benefits from M&A transactions
Corporate Governance

Distribution 2020 (proposed)
CHF 3.40

(2019: CHF 3.05)
Dividend policy

Corporate Governance Report
Directors' Dealings
Announcements
Share Buyback

Upcoming Event

21.02.2020:

Annual report 2019, 7 a.m.

CALENDAR

EN

Portfolio

Portfolio composition as at 12/31/2019

Breakdown by sector as at 12/31/2019

Capitaliziation

Breakdown by currency as at 12/31/2019

Market capitalization as at 12/31/2019

Portfolio